Evidence map›Paper›PMID 26582578›Full record

ArticleEuropean journal of nutrition2017

Increased dietary levels of α-linoleic acid inhibit mammary tumor growth and metastasis.

Marianela Vara-Messler, Maria E Pasqualini, Andrea Comba, Renata Silva, Carola Buccellati, Annalisa Trenti, Lucia Trevisi, Aldo R Eynard, Angelo Sala, Chiara Bolego and 1 more

Erratum issuedOpen access · bronzeAbstract read
PubMed Publisher
In one paragraph

Article in European journal of nutrition, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 19 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed, 1 pooled it
2.0field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 1 synthesis or guideline pooled it, 48 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Emerging targets in lipid metabolism for cancer therapy.Trends in pharmacological sciences · 2024
    Review
  6. The Antitumor Effects of α-Linolenic Acid.Journal of personalized medicine · 2024
    Review
  7. Article
  8. Article
  9. Article
  10. Frontiers in pharmacology · 2022
    Article
  11. Review
  12. Review
  13. Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Review
  19. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

11 authors at 5 institutions in 2 countries.

Marianela Vara-MesslerInstituto de Investigaciones en Ciencias de la Salud de Córdoba (INICSA-CONICET), Universidad Nacional de Córdoba, Enrique Barros s/n. Ciudad Universitaria, 5000, Córdoba, Argentina.
Maria E PasqualiniInstituto de Investigaciones en Ciencias de la Salud de Córdoba (INICSA-CONICET), Universidad Nacional de Córdoba, Enrique Barros s/n. Ciudad Universitaria, 5000, Córdoba, Argentina.
Andrea CombaInstituto de Investigaciones en Ciencias de la Salud de Córdoba (INICSA-CONICET), Universidad Nacional de Córdoba, Enrique Barros s/n. Ciudad Universitaria, 5000, Córdoba, Argentina.
Renata SilvaInstituto de Investigaciones en Ciencias de la Salud de Córdoba (INICSA-CONICET), Universidad Nacional de Córdoba, Enrique Barros s/n. Ciudad Universitaria, 5000, Córdoba, Argentina.
Carola BuccellatiDepartment of Pharmacological and Biomolecular Sciences, University of Milan, Via Balzaretti 9, 20133, Milan, Italy.
Annalisa TrentiDepartment of Pharmaceutical and Pharmacological Sciences, University of Padua, Largo E. Meneghetti 2, 35131, Padua, Italy.
Lucia TrevisiDepartment of Pharmaceutical and Pharmacological Sciences, University of Padua, Largo E. Meneghetti 2, 35131, Padua, Italy.
Aldo R EynardInstituto de Investigaciones en Ciencias de la Salud de Córdoba (INICSA-CONICET), Universidad Nacional de Córdoba, Enrique Barros s/n. Ciudad Universitaria, 5000, Córdoba, Argentina.
Angelo SalaDepartment of Pharmacological and Biomolecular Sciences, University of Milan, Via Balzaretti 9, 20133, Milan, Italy.
Chiara BolegoDepartment of Pharmaceutical and Pharmacological Sciences, University of Padua, Largo E. Meneghetti 2, 35131, Padua, Italy.
Mirta A ValentichInstituto de Investigaciones en Ciencias de la Salud de Córdoba (INICSA-CONICET), Universidad Nacional de Córdoba, Enrique Barros s/n. Ciudad Universitaria, 5000, Córdoba, Argentina. mirtavalentich@gmail.com.
Universidad Nacional de Córdoba · ARUniversity of Padua · ITInstituto de Investigaciones en Ciencias de la Salud · ARUniversity of Milan · ITConsejo Nacional de Investigaciones Científicas y Técnicas · AR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveThe aim of this study was to determine whether α-linolenic acid (ALA ω-3 fatty acid) enriched diet affects growth parameters when applied to a syngeneic model of mammary carcinoma. MATERIALS AND

methodsBALB/c mice were divided and fed with: 1) a chia oil diet, rich in ALA or 2) a corn oil diet, rich in linoleic acid (LA ω-6 fatty acid). Mice were subcutaneously inoculated with a tumor cell line LM3, derived from a murine mammary adenocarcinoma.

resultsAfter 35 days, tumor incidence, weight, volume and metastasis number were lower in the ALA-fed mice, while tumor latency time was higher, and the release of pro-tumor metabolites derived from ω-6 fatty acids decreased in the tumor. Compared to the control group, a lower number of mitosis, a higher number of apoptotic bodies and higher T-lymphocyte infiltration were consistently observed in the ALA group. An ALA-rich diet decreased the estrogen receptor (ER) α expression, a recognized breast cancer promotor while showing an opposite effect on ERβ in tumor lysates.

conclusionThese data support the anticancer effect of an ALA-enriched diet, which might be used as a dietary strategy in breast cancer prevention.

Indexed as

Dietalpha-Linolenic AcidAnimalsApoptosisCell Line, TumorCorn OilEstrogen Receptor alphaEstrogen Receptor betaFatty Acids, Omega-3Fatty Acids, Omega-6FemaleLinoleic AcidMaleMammary Neoplasms, ExperimentalMiceMice, Inbred BALB Calpha-Linolenic AcidCorn OilEstrogen Receptor alphaEstrogen Receptor betaFatty Acids, Omega-3Fatty Acids, Omega-6Linoleic AcidPlant OilsChia oilEstrogen receptorLOXs metabolitesMammary carcinomaα-linolenic acid (ALA)

Identifiers

PMID26582578
OpenAlexW2174902421

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.